Switching from Intravitreal Ranibizumab to Bevacizumab for Age-Related Macular Degeneration
Purpose. To report our experiences in patients with age-related macular degeneration (AMD) treated initially with intravitreal ranibizumab and then switched to bevacizumab. Methods. We retrospectively reviewed the records of 7 patients (7 eyes) who were treated with monthly injections of intravitre...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
International Scholarly Research Network
2011
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912580/ |